Developer docs
API playgroundTry for free, no card

Search company profiles

Canadian Plasma Resources.

Full company profile

uuid002c5jq

Namestring
Canadian Plasma Resources.
Legal namestring
Grifols Shared Services North America, Inc.
Websiteurl
giveplasma.ca
Company typeenum
Private
Founded yearint
2009
Descriptiontext

Canadian Plasma Resources (CPR) is a Canadian source plasma collection operator and a wholly-owned subsidiary of Grifols, S.A. (NASDAQ: GRFS), the Spanish multinational pharmaceutical company. Founded in 2009 and headquartered administratively in Oakville, Ontario (with Saskatoon also listed as an operating city), CPR operates 16 plasma collection centers across Canada. The company's stated positioning is to expand Canada's domestic plasma supply, addressing the structural reality that more than 70% of plasma fractionated for Canadian patients is currently sourced from the United States.

CPR's core product is source plasma collected via plasmapheresis from compensated donors. Its operating protocol includes a four-layer donor screening process, a 60-day plasma inventory quarantine, and viral inactivation steps aligned with pharmaceutical-grade plasma specifications for downstream fractionation. The company runs a direct-to-consumer donor acquisition model, recruiting donors through its giveplasma.ca consumer platform and compensating them at up to approximately $100 per donation, supplemented by loyalty (Super Hero Rewards) and referral programs. The iCASI electronic donor questionnaire system has been deployed to digitize the intake process and standardize screening.

Commercially, CPR is structured as a vertically integrated collection arm within Grifols' global plasma supply network. Collected source plasma feeds Grifols' fractionation infrastructure, where it is manufactured into plasma-derived therapies (immunoglobulins, albumin, coagulation factors) for patients with rare and chronic conditions. CPR's effective off-take is its parent Grifols; donor-side revenue mechanics are consumer-facing (per-donation compensation) rather than enterprise contracting. Firmographic data indicates a headcount range of 11–50 employees, likely reflecting corporate and administrative staff rather than total collection-site workforce.

Short descriptiontext

Canadian Plasma Resources operates 16 plasma collection centers across Canada as a wholly-owned subsidiary of Grifols, S.A., collecting source plasma from compensated donors via plasmapheresis to supply Grifols' downstream plasma-derived therapy manufacturing network.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSaskatoon, Canada
HQ citystring
Saskatoon
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices17 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
plasma collection services, source plasma donation, plasmapheresis services, plasma protein therapies, paid donor programs
Industry3 codes
PRIMARYHLAIAHAH
Plasma Collection & Donor Services (Plasmapheresis Centers)
SECONDARYHLAIAHAL
Plasma-Derived Therapy Cold Chain & Specialty Logistics
SECONDARYHLAIAHAK
Plasma-Derived Therapy Quality, Safety & Pharmacovigilance (Pathogen Reduction/Testing)
NAICS code1 code
  • Blood and Organ Banks621991
Product category
Plasma Collection Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Source Plasma Collection and Manufacturing
TypeHardware Sales
Description

Grifols collects source plasma from paid donors at its Canadian Plasma Resources centers. The plasma is manufactured into plasma protein therapies (immunoglobulin, albumin, coagulation factors, alpha-1 antitrypsin, etc.) and sold globally to healthcare providers and patients. Revenue is generated through the sale of plasma-derived pharmaceutical products manufactured from collected raw plasma.

giveplasma.ca
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain
Pricing details1 tier
1Standard per-donation compensation — up to $100 per donation
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Qualified donors receive up to $100 per plasma donation. Donors can give plasma up to twice per rolling 7-day period with a minimum 2-day gap between donations. Unusable donations (below minimum volume, hyperlipidemic, or with excess red blood cells) receive $10. Donor compensation increases through the Super Hero Rewards loyalty program with three tiers (Orange, Silver, Gold) based on donation frequency. Referral Rewards program pays $25–$50 per referred donor depending on monthly referral volume.

giveplasma.ca
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 2 records shown
1Super Hero Rewards
Description

Donor loyalty program enabling donors to receive bonus compensation based on donation frequency, with Orange, Silver, and Gold levels.

giveplasma.ca
+1 more record
Core offering1 text field

Canadian Plasma Resources collects source plasma from compensated donors through plasmapheresis at 16 Health Canada-licensed collection centers across Canada. Collected plasma serves as raw material for manufacturing plasma protein therapies (immunoglobulin, albumin, coagulation factors, alpha-1 antitrypsin) used to treat patients with immune deficiencies, autoimmune diseases, hemophilia, and other conditions. The company supplements core collection with a tiered donor loyalty program and a paid referral program.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Over 70% of plasma used in Canada is sourced from the US — CPR/Grifols addresses this gap by collecting plasma domestically
+2 more records
Product overview1 text field

Canadian Plasma Resources, operated by Grifols, operates a network of plasma collection centers across Canada offering plasma donation services through plasmapheresis. The core offering is source plasma collection for manufacturing into plasma protein therapies. Supporting programs include the Super Hero Rewards loyalty program (providing tiered bonus compensation based on donation frequency) and the Referral Rewards program (compensating donors for referring new donors). The company also uses an internal iCASI electronic questionnaire system for donor health screening. Donors receive compensation of up to $100 per donation, and plasma is processed into therapies for patients with immune deficiencies, autoimmune disorders, hemophilia, and other conditions.

Product and service3 records
1Plasma Donation Services
CategoryCore plasma collection service
Description

Collection of source plasma from qualified donors through plasmapheresis at 16 Health Canada-licensed centers across Canada. Collected plasma serves as raw material for manufacturing plasma protein therapies (immunoglobulin, albumin, coagulation factors, alpha-1 antitrypsin) for patients with immune deficiencies, autoimmune diseases, hemophilia, and related conditions.

2Super Hero Rewards Loyalty Program
CategoryLoyalty and retention program
Description

Tiered donor loyalty program (Orange, Silver, Gold levels) enabling donors to earn bonus compensation by donating plasma twice per week for consecutive weeks, reinforcing retention of frequent donors.

3Referral Rewards Program
CategoryReferral program
Description

Paid referral program that compensates existing donors $25-$50 per referred donor who completes a plasma donation, with higher tiers based on monthly referral volume (4-6, 7-9, or 10+ referrals).

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Spanish multinational parent of CPR and one of the world's largest manufacturers of plasma-derived therapies. Comparable as the integrated owner of plasma collection, fractionation, and finished-product distribution that CPR supplies raw plasma into.

TypeDirect peer
Description

Swiss-headquartered vertically integrated plasma therapeutics company that operates its own source plasma collection centers. Comparable as a private plasma collector and fractionator with a global footprint.

TypeDirect peer
Description

UK-based plasma fractionator with owned plasma collection operations in the U.S. Comparable as a vertically integrated competitor in source plasma collection for plasma-derived therapies.

TypeRegional player
Description

Canada's national not-for-profit blood and plasma operator (outside Quebec). Comparable as a domestic Canadian plasma collector but operates on a non-compensated donor model, positioning it as CPR's principal public-policy counterweight.

TypeDirect peer
Description

U.S.-based plasma collection network owned by Takeda Pharmaceutical Company. Operates a comparable paid-donor, multi-center collection model with loyalty/referral programs and feeds into Takeda's plasma-derived therapy franchise.

TypeDirect peer
Description

Italian plasma-derived therapies company that collects source plasma through owned and partner centers in the U.S. and Europe. Comparable as a private integrated plasma collector/fractionator competing for the same raw-input supply chain.

TypeEmerging player
Description

U.S.-based commercial-stage biopharmaceutical company specializing in plasma-derived immune globulin products for immune-deficient patients. Comparable as a downstream buyer/competitor in the plasma-derived therapy value chain CPR ultimately feeds.

TypeRegional player
Description

Québec's not-for-profit blood and plasma operator. Comparable as a Canadian regional plasma collector using a non-paid donor model, representing an alternative domestic supply model in the Canadian market.

TypeBroad incumbent
Description

Japanese pharmaceutical major that owns BioLife Plasma Services. Comparable as the broader parent of a major paid-plasma collection competitor and a global plasma-derived therapy franchise (e.g., Gammagard, Hyqvia).

TypeDirect peer
Description

Largest global plasma collection network, subsidiary of CSL Behring (CSL Limited). Directly comparable as a paid-donor source plasma collector using a similar multi-center retail-style donor experience model.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Canadian Plasma Resources.

Plasma Collection Servicesgiveplasma.ca

Canadian Plasma Resources operates 16 plasma collection centers across Canada as a wholly-owned subsidiary of Grifols, S.A., collecting source plasma from compensated donors via plasmapheresis to supply Grifols' downstream plasma-derived therapy manufacturing network.

What Canadian Plasma Resources. does

Canadian Plasma Resources (CPR) is a Canadian source plasma collection operator and a wholly-owned subsidiary of Grifols, S.A. (NASDAQ: GRFS), the Spanish multinational pharmaceutical company. Founded in 2009 and headquartered administratively in Oakville, Ontario (with Saskatoon also listed as an operating city), CPR operates 16 plasma collection centers across Canada. The company's stated positioning is to expand Canada's domestic plasma supply, addressing the structural reality that more than 70% of plasma fractionated for Canadian patients is currently sourced from the United States.

CPR's core product is source plasma collected via plasmapheresis from compensated donors. Its operating protocol includes a four-layer donor screening process, a 60-day plasma inventory quarantine, and viral inactivation steps aligned with pharmaceutical-grade plasma specifications for downstream fractionation. The company runs a direct-to-consumer donor acquisition model, recruiting donors through its giveplasma.ca consumer platform and compensating them at up to approximately $100 per donation, supplemented by loyalty (Super Hero Rewards) and referral programs. The iCASI electronic donor questionnaire system has been deployed to digitize the intake process and standardize screening.

Commercially, CPR is structured as a vertically integrated collection arm within Grifols' global plasma supply network. Collected source plasma feeds Grifols' fractionation infrastructure, where it is manufactured into plasma-derived therapies (immunoglobulins, albumin, coagulation factors) for patients with rare and chronic conditions. CPR's effective off-take is its parent Grifols; donor-side revenue mechanics are consumer-facing (per-donation compensation) rather than enterprise contracting. Firmographic data indicates a headcount range of 11–50 employees, likely reflecting corporate and administrative staff rather than total collection-site workforce.

Canadian Plasma Resources. firmographics

Firmographics
Name
Canadian Plasma Resources.
Legal name
Grifols Shared Services North America, Inc.
Website
https://giveplasma.ca
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
51–100 employees
Short description
Canadian Plasma Resources operates 16 plasma collection centers across Canada as a wholly-owned subsidiary of Grifols, S.A., collecting source plasma from compensated donors via plasmapheresis to supply Grifols' downstream plasma-derived therapy manufacturing network.
Ownership category
akta.pro rank

Canadian Plasma Resources. industry classification

Industry
Product category
Plasma Collection Services
NAICS
Blood and Organ Banks (621991)
akta.pro industry
PRIMARYHLAIAHAH
Plasma Collection & Donor Services (Plasmapheresis Centers)
SECONDARYHLAIAHAL
Plasma-Derived Therapy Cold Chain & Specialty Logistics
SECONDARYHLAIAHAK
Plasma-Derived Therapy Quality, Safety & Pharmacovigilance (Pathogen Reduction/Testing)

Keywords

  • Plasma collection services
  • Source plasma donation
  • Plasmapheresis services
  • Plasma protein therapies
  • Paid donor programs

Where Canadian Plasma Resources. is headquartered

Location

Headquarters

HQ city
Saskatoon
HQ country
Canada
HQ region
North America

Offices17 records

Markets served

Canadian Plasma Resources. business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

  1. Source Plasma Collection and Manufacturing: Grifols collects source plasma from paid donors at its Canadian Plasma Resources centers. The plasma is manufactured into plasma protein therapies (immunoglobulin, albumin, coagulation factors, alpha-1 antitrypsin, etc.) and sold globally to healthcare providers and patients. Revenue is generated through the sale of plasma-derived pharmaceutical products manufactured from collected raw plasma.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goStandard per-donation compensation — up to $100 per donation

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Canadian Plasma Resources. product offering

Product offering

Core offering

Canadian Plasma Resources collects source plasma from compensated donors through plasmapheresis at 16 Health Canada-licensed collection centers across Canada. Collected plasma serves as raw material for manufacturing plasma protein therapies (immunoglobulin, albumin, coagulation factors, alpha-1 antitrypsin) used to treat patients with immune deficiencies, autoimmune diseases, hemophilia, and other conditions. The company supplements core collection with a tiered donor loyalty program and a paid referral program.

Product overview

Canadian Plasma Resources, operated by Grifols, operates a network of plasma collection centers across Canada offering plasma donation services through plasmapheresis. The core offering is source plasma collection for manufacturing into plasma protein therapies. Supporting programs include the Super Hero Rewards loyalty program (providing tiered bonus compensation based on donation frequency) and the Referral Rewards program (compensating donors for referring new donors). The company also uses an internal iCASI electronic questionnaire system for donor health screening. Donors receive compensation of up to $100 per donation, and plasma is processed into therapies for patients with immune deficiencies, autoimmune disorders, hemophilia, and other conditions.

Differentiator

Problem solved

Functional benefit

Brands

  • Super Hero Rewards: Donor loyalty program enabling donors to receive bonus compensation based on donation frequency, with Orange, Silver, and Gold levels.
  • Referral Rewards

Products and services

  • Plasma Donation Services Collection of source plasma from qualified donors through plasmapheresis at 16 Health Canada-licensed centers across Canada. Collected plasma serves as raw material for manufacturing plasma protein therapies (immunoglobulin, albumin, coagulation factors, alpha-1 antitrypsin) for patients with immune deficiencies, autoimmune diseases, hemophilia, and related conditions.
  • Super Hero Rewards Loyalty Program Tiered donor loyalty program (Orange, Silver, Gold levels) enabling donors to earn bonus compensation by donating plasma twice per week for consecutive weeks, reinforcing retention of frequent donors.
  • Referral Rewards Program Paid referral program that compensates existing donors $25-$50 per referred donor who completes a plasma donation, with higher tiers based on monthly referral volume (4-6, 7-9, or 10+ referrals).

Quantifiable outcome

  • Over 70% of plasma used in Canada is sourced from the US — CPR/Grifols addresses this gap by collecting plasma domestically
  • +2 more outcomes

Companies that use Canadian Plasma Resources.

Customer profile

Named customers6 records

Segments1 record

Ideal customer profiles2 records

Canadian Plasma Resources. technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Canadian Plasma Resources. partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Canadian Plasma Resources. competitors and assessment

Company assessment

Broad incumbents

  • Grifols S.A. Spanish multinational parent of CPR and one of the world's largest manufacturers of plasma-derived therapies. Comparable as the integrated owner of plasma collection, fractionation, and finished-product distribution that CPR supplies raw plasma into.
  • Takeda Pharmaceutical Company: Japanese pharmaceutical major that owns BioLife Plasma Services. Comparable as the broader parent of a major paid-plasma collection competitor and a global plasma-derived therapy franchise (e.g., Gammagard, Hyqvia).

Direct peers

  • Octapharma: Swiss-headquartered vertically integrated plasma therapeutics company that operates its own source plasma collection centers. Comparable as a private plasma collector and fractionator with a global footprint.
  • Bio Products Laboratory (BPL): UK-based plasma fractionator with owned plasma collection operations in the U.S. Comparable as a vertically integrated competitor in source plasma collection for plasma-derived therapies.
  • BioLife Plasma Services: U.S.-based plasma collection network owned by Takeda Pharmaceutical Company. Operates a comparable paid-donor, multi-center collection model with loyalty/referral programs and feeds into Takeda's plasma-derived therapy franchise.
  • Kedrion Biopharma: Italian plasma-derived therapies company that collects source plasma through owned and partner centers in the U.S. and Europe. Comparable as a private integrated plasma collector/fractionator competing for the same raw-input supply chain.
  • CSL Plasma: Largest global plasma collection network, subsidiary of CSL Behring (CSL Limited). Directly comparable as a paid-donor source plasma collector using a similar multi-center retail-style donor experience model.

Regional players

  • Canadian Blood Services: Canada's national not-for-profit blood and plasma operator (outside Quebec). Comparable as a domestic Canadian plasma collector but operates on a non-compensated donor model, positioning it as CPR's principal public-policy counterweight.
  • Héma-Québec: Québec's not-for-profit blood and plasma operator. Comparable as a Canadian regional plasma collector using a non-paid donor model, representing an alternative domestic supply model in the Canadian market.

Emerging players

  • ADMA Biologics: U.S.-based commercial-stage biopharmaceutical company specializing in plasma-derived immune globulin products for immune-deficient patients. Comparable as a downstream buyer/competitor in the plasma-derived therapy value chain CPR ultimately feeds.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Canadian Plasma Resources. social profiles

Digital presence

Canadian Plasma Resources. financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Canadian Plasma Resources. leadership team

Management profile

Number of profiles

Canadian Plasma Resources. funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Canadian Plasma Resources. M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Canadian Plasma Resources.

What does Canadian Plasma Resources. do?

Canadian Plasma Resources collects source plasma from compensated donors through plasmapheresis at 16 Health Canada-licensed collection centers across Canada. Collected plasma serves as raw material for manufacturing plasma protein therapies (immunoglobulin, albumin, coagulation factors, alpha-1 antitrypsin) used to treat patients with immune deficiencies, autoimmune diseases, hemophilia, and other conditions. The company supplements core collection with a tiered donor loyalty program and a paid referral program.

Is Canadian Plasma Resources. a public or private company?

Canadian Plasma Resources. is a private company. It is classified as corporate owned and is currently operating.

When was Canadian Plasma Resources. founded?

Canadian Plasma Resources. was founded in 2009. It employs 51 to 100 people.

Where is Canadian Plasma Resources. based?

Canadian Plasma Resources. is headquartered in Saskatoon, Canada, in the North America region.

How does Canadian Plasma Resources. make money?

One revenue line is on record: source Plasma Collection and Manufacturing.

Who are Canadian Plasma Resources.'s main competitors?

Broad incumbents on record are Grifols S.A. and Takeda Pharmaceutical Company. Direct peers are Octapharma, Bio Products Laboratory (BPL), BioLife Plasma Services, Kedrion Biopharma and CSL Plasma. Regional players are Canadian Blood Services and Héma-Québec. ADMA Biologics is listed as an emerging player.

Does Canadian Plasma Resources. have an API?

No public API is recorded for Canadian Plasma Resources..

What industry is Canadian Plasma Resources. in?

Canadian Plasma Resources.'s product category is Plasma Collection Services. Its primary akta.pro industry code is HLAIAHAH, Plasma Collection & Donor Services (Plasmapheresis Centers), with a secondary code of HLAIAHAL, Plasma-Derived Therapy Cold Chain & Specialty Logistics. Its NAICS code is 621991.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales